期刊文献+

极晚期支架内血栓的研究进展——发病机制及防治策略 被引量:2

Advances in Research in Very Late Thrombosis after Stent Implantation—Mechanism and Methods of Prevention
下载PDF
导出
摘要 药物洗脱支架应用于临床后,支架血栓问题引起广泛关注。目前的研究资料表明药物支架与金属裸支架相比并不引起更多的早、晚期支架内血栓的发生,但极晚期支架血栓形成的风险增加。极晚期支架发生机制复杂,临床多表现为严重的心血管事件,应予以积极防治。现综述极晚期支架内血栓的相关研究进展。 Drug-eluting stents are widely used during percutaneous coronary intervention.Compared to a bare-metal stent,the risk of very late stent thrombosis appears to be higher in drug-eluting stent.The mechanism of very late stent thrombosis is complicated,and the prevention of very late stent thrombosis after drug-eluting stent implantation is critical.This article assesses current mechanisms methods of preventing very late stent thrombosis after drug-eluting stent implantation.
出处 《心血管病学进展》 CAS 2011年第6期850-854,共5页 Advances in Cardiovascular Diseases
关键词 冠状动脉 极晚期支架内血栓 药物洗脱支架 coronary artery very late stent thrombosis drug-eluting stent
  • 相关文献

参考文献34

  • 1Hill R,Bagust A,Bakhai A,et al.Coronary artery stents:a rapid systematic review and economic evaluation[J].Health Technol Assess,2004,8(35):iiiiv,1.
  • 2Serruys PW,Kutryk MJ,Ong AT.Coronary artery stents[J].N Engl J Mnd,2006,354:483-495.
  • 3Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007,115(17):2344-2351.
  • 4Daemen J,Wenaweser P,Tsuchida K,et al.Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:data from a large two-institutional cohort study[J].Lancet,2007,369(9562):667-678.
  • 5Pinto Slottow TL,Steinberg DH,Roy PK,et al.Observations and outeomee of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period[J].Am J Cardiol,2008,102(3):298-303.
  • 6Vaknin-Assa H,Assali A,Ukabi S,et al.Stent thrombosis following drug-eluting stent implantation.A single-center experience[J].Cardiovasc Revasc Med,2007,8 (4):243-247.
  • 7Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J].N Engl J Med,2007,356(10):1020-1029.
  • 8Stettler C,Wandel S,Allemann S,et al.Outcomes associated with drug-eluring and bare-metal stents:a collaborative networrk meta-analysis[J].Lancet,2007,370(9591):937-948.
  • 9Kastrati A,Mehilli J,Pache J,et al.Analysis of 14 trials comparing sirolimuseluting stents with bare-metal stents[J].N Engl J Med,2007,356(10):1030-1039.
  • 10Bavry AA,Kumbhani DJ,Helton TJ,et al.Late thrombosis of drug-eluting stents:a meta-analysis of randomized clinical trials[J].Am J Med,2006,119(12):1056-1061.

二级参考文献6

  • 1Kuchulakanti P,Chu W,Torguson R,et al.Correlates and long term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel eluting stents.Circulation,2006,113:1108-1113.
  • 2Luscher TF,Steffel J,Eberli FR,et al.Drug-eluting stent and coronary thrombosis:Biological mechanisms and clinical implications.Circulation,2007,115:1051-1058.
  • 3Kotani JI,Awata M,Nanto S,et al.Incomplete neointimal coverage of sirolimus eluting stents:Angioscopic findings.J Am Coll Cardiol,2006,47:2108-2111.
  • 4Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA,2005,293:2126-2130.
  • 5Virmani R,Guagliumi G,Farb A,et al.Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent:Should we be cautious? Circulation,2004,109:701-705.
  • 6Lee MS,Jurewitz D,Aragon J,et al.Stent fracture associated with drug-eluting stents:Clinical characteristics and implications.Catheter Cardiovasc Interv,2007,69:387-394.

共引文献3

同被引文献17

  • 1梁峰,沈珠军,胡大一.Cypher支架的临床应用评价[J].中华临床医师杂志(电子版),2011,5(20):6065-6071. 被引量:3
  • 2Kato M. Kimura T. Morimoto T, Nishikawa H, LJchida F.Suzu-ki H,et al. Comparison of five-year outcome of sirolimus-elutingstent implantation for chronic total occlusions versus for non-chronic total occlusion (from the j-Cypher Registry) [J ]. Am JCardiol,2012,110: 1282-1289.
  • 3Nakagawa Y, Kimura T,Morimoto T,Nomura M, Saku K,Ha-ruta S.et al. Incidence and risk factors of late target lesion re-vascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) [J]. Am J Cardiol.2010,106: 329-336.
  • 4Cutlip D E, Windecker S. Mehran R, Boam A,Cohen D J , van EsG A,et al. Clinical end points in coronary stent trials: a case forstandardized definitions[J]. Circulation, 2007,1 15: 2344.2351.
  • 5D Ascenzo P'.Bollati M,dementi F.Castagno D,Lagerqvist B,dc la Torre Hernandez J M. et al. Incidence and predictors ofcoronary stent thrombosis: Evidence from an international col-laborative meta-analysis including 30 studies.221,066 patients,and 4276 thromhoses[J]. Int J Cardiol, 2012 Feh 21, [Epub a-head of print].
  • 6Holmes D R Jr, Kereiakes D J .Garg S,Serruys P W, Dehmer DJ . Ellis S G, et al. Stent thrombosis [J].J Am Coll Cardiol.2010,56:1357-1365.
  • 7Waksman R, Pakala R. Biodegradable and bioabsorbable stents[J]. Curr Pharm Des,2010,16 :4041-4051.
  • 8Cutlip DE,Windecker S,Mehran R. Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007.2344-2351.
  • 9Pinto Slottow TL,Steinberg DH,Roy PK. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period[J].American Journal of Cardiology,2008.298-303.
  • 10Lanzer P,Sternberg K,Schmitz KP. Drug-eluting coronary stent very late thrombosis revisited[J].Herz,2008.334-342.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部